SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oxford Health Plan (OXHP) -- Ignore unavailable to you. Want to Upgrade?


To: Jeff Mills who wrote (320)12/4/1997 11:14:00 PM
From: LoLoLoLita  Respond to of 2068
 
The Price-to-Sales ratio is low, but so is the profit margin,
ROE, and ROA, and that's not new. The thing that propelled
this stock up was the steady growth (no losing quarter ever,
till now), and the perception that management could do no wrong.
This company saw explosive share price growth because people
thought that history would keep repeating itself.

This belief was so strong that most holders ignored the bad news about billing problems that circulated last July-August (I have an S&P Report from 8/97 that called the problems "widely publicized"--yet we have all these crybaby class action lawsuits from people who I guess can't read!)

It's bad PR that the company hasn't put out anything about the
groundlessness of the lawsuits. ASND took about 23 hours to
respond to their crybabies:

biz.yahoo.com

And it sure does look bad that we broke through support today
by a full point on high volume.

Let's hope that Wiggins didn't go to Robbie Stephens because
he had to go to DC to work out a takeover deal. Otherwise,
we're going to be in for a long-term holding to see profits.

Cheers, David

(long OXHP, COMS, ASND, VLSI, LSI, and some dish drivers I don't want
to mention. in other words, a bottom feeder)



To: Jeff Mills who wrote (320)12/4/1997 11:45:00 PM
From: Peter  Respond to of 2068
 
Please, please, don't use the MEDA analogy.....that stock is dog ----!